Next Science | Investor Centre

Next Science Limited is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. It is listed on the ASX under ASX Code ‘NXS’. Next Science’s primary focus is the development and continued commercialisation of its proprietary Xbio^TM technology to reduce the impact of biofilm based infections in human health.

Half Year & Full Year Reports

Period Ending	Report	Webcast	Results Release
2023 Half Year Results	Opens in new window		Opens in new window
2022 Half Year Results	Opens in new window
2021 Full Year Results	Opens in new window		Opens in new window
2021 Half Year Results	Opens in new window
2021 Annual Report	Opens in new window
2020 Annual Report	Opens in new window
2020 Full Year Results	Opens in new window	Opens in new window	Opens in new window
2020 Half Year Results	Opens in new window	Opens in new window	Opens in new window

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 8607 5124
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474